Drug and vaccine authorizations for COVID-19: List of authorized drugs, vaccines and expanded indications
Date published: 2021-07-30
Drugs and vaccines that have been authorized by Health Canada for use in relation to the COVID-19 pandemic are listed here.
In the list below, the entry for each authorized drug and vaccine includes the:
- authorization holder
- brand name, proper name or common name, linked to the rationale for authorizing the product for use against COVID-19
- medicinal ingredient(s), strength, dosage form and route of administration
- drug identification number (DIN), linked to the entry for the product in the Drug Product Database, which includes the product monograph
- therapeutic area (using the World Health Organization's coding system)
- Health Canada's control number for the application
- date of authorization
- how the drug or vaccine was authorized
In the "authorization" column, there are 4 possible scenarios for each drug or vaccine:
- The product was submitted by the company to Health Canada and authorized under the Food and Drug Regulations
- The product was submitted by the company for review under section 3 of the interim order and authorized
- The product was submitted by the company for review under section 4 of the interim order and authorized
- The product was added to the List of New Drugs for Expanded Indication in Relation to the COVID-19 Pandemic by Health Canada, under section 15 of the interim order
- Date modified:
No comments:
Post a Comment